Extending the targets for antihypertensive drugs.
作者信息
Bonn D
出版信息
Lancet. 1998 Aug 1;352(9125):378. doi: 10.1016/S0140-6736(05)60483-7.
PMID:9717937
Abstract
摘要
相似文献
1
Extending the targets for antihypertensive drugs.
Lancet. 1998 Aug 1;352(9125):378. doi: 10.1016/S0140-6736(05)60483-7.
2
Peptides as targets for antihypertensive drug development.作为抗高血压药物开发靶点的肽类
J Hypertens Suppl. 1992 Dec;10(7):S121-32.
3
[Hypertension in patients with cardiac hypertrophy].[心脏肥大患者的高血压]
Nihon Rinsho. 2004 Mar;62 Suppl 3:471-7.
4
Experience with angiotensin II antagonists in hypertensive patients.高血压患者应用血管紧张素 II 拮抗剂的经验。
Clin Exp Pharmacol Physiol. 1996 Sep;23 Suppl 3:S142-6. doi: 10.1111/j.1440-1681.1996.tb03076.x.
5
[Effect of angiotensin II and antagonists of the renin-angiotensin system on the cerebral circulation].
Eksp Klin Farmakol. 2000 Jul-Aug;63(4):74-9.
6
Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.用于治疗高血压及相关疾病的新型肾素-血管紧张素-醛固酮系统阻断疗法。
J Hypertens. 2007 Jan;25(1):25-35. doi: 10.1097/HJH.0b013e3280113950.
7
[Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].[治疗前景：血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂的联合应用]
Clin Ter. 2001 Mar-Apr;152(2):77-8.
8
Renin-angiotensin-aldosterone system inhibitors in heart failure.肾素-血管紧张素-醛固酮系统抑制剂在心力衰竭中的应用。
Clin Pharmacol Ther. 2013 Oct;94(4):459-67. doi: 10.1038/clpt.2013.135. Epub 2013 Jul 12.
9
Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.血管紧张素II 1型受体阻断：心血管药理学的新进展。
Int J Clin Pract. 1998 Oct;52(7):475-81.
10
[Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].血管紧张素转换酶抑制剂与血管紧张素II拮抗剂的效果比较
Therapie. 1998 May-Jun;53(3):253-70.
Zotero 插件